Lys340
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Ubiquitylation Site Page:
Lys340 - HLAA iso36 (human)

Site Information
RRKSSDRkGGSYTQA   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: HLAA iso31 (human): K340, HLAA iso25 (human): K340, HLAA (human): K340, HLAA iso3 (human): K340, HLAA iso23 (human): (K340), HLAA iso80 (human): (K340), HLAA (mouse): (‑), HLAA iso24 (human): (K340)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 12319454

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 3)
Disease tissue studied: lung cancer (1), non-small cell lung adenocarcinoma (1)
Relevant cell line - cell type - tissue: A549 (pulmonary) (1), Jurkat (T lymphocyte) (2)




References

1

Wu Q, et al. (2015) Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep 5, 9520
25825284   Curated Info

2

Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7
23749302   Curated Info

3

Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44, 325-40
21906983   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.